Related Experiment Videos
Bullous pemphigoid treated by topical corticosteroids
P Paquet1, M Richelle, C M Lapiere
1Department of Dermatology, CHU-Liège, Belgium.
Acta Dermato-Venereologica
|January 1, 1991
Summary
Topical corticosteroids effectively treated limited bullous pemphigoid in three patients. For extensive cases, additional systemic therapy may be necessary, highlighting minimal side effects of topical treatments.
Area of Science:
- Dermatology
- Immunodermatology
Background:
- Bullous pemphigoid (BP) is an autoimmune blistering disease.
- Treatment options for BP vary in efficacy and side effect profiles.
Observation:
- Three patients with bullous pemphigoid were treated solely with topical corticosteroids (clobetasol propionate).
- One patient required the addition of systemic corticosteroid therapy.
Findings:
- Topical corticosteroid monotherapy achieved successful treatment in limited bullous pemphigoid.
- Topical corticosteroids offer a valuable treatment alternative for limited BP due to minimal side effects.
- Extensive forms of bullous pemphigoid may require more intensive treatment beyond topical corticosteroids.
Implications:
- Topical corticosteroid therapy is a viable and safe option for managing limited bullous pemphigoid.
- This approach minimizes systemic side effects associated with long-term corticosteroid use.
- Further research may explore combination therapies for extensive bullous pemphigoid.